Mina Ebrahimi‐Rad

825 total citations
33 papers, 628 citations indexed

About

Mina Ebrahimi‐Rad is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Mina Ebrahimi‐Rad has authored 33 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Mina Ebrahimi‐Rad's work include Antibiotic Resistance in Bacteria (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Transgenic Plants and Applications (3 papers). Mina Ebrahimi‐Rad is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Transgenic Plants and Applications (3 papers). Mina Ebrahimi‐Rad collaborates with scholars based in Iran, Spain and Netherlands. Mina Ebrahimi‐Rad's co-authors include Reza Saghiri, Pablo Bifani, Kristin Kremer, Carlos Martı́n, Jean Rauzier, Sofía Samper, Marc Jouan, Barry N. Kreiswirth, Dick van Soolingen and Jesús Blázquez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Mina Ebrahimi‐Rad

33 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mina Ebrahimi‐Rad Iran 14 299 299 157 131 59 33 628
Walid Ben-Selma Tunisia 15 283 0.9× 231 0.8× 87 0.6× 104 0.8× 97 1.6× 29 619
Alida R. Ovrutsky United States 11 357 1.2× 289 1.0× 88 0.6× 147 1.1× 28 0.5× 16 687
Norberto González-Juarbe United States 16 446 1.5× 198 0.7× 48 0.3× 418 3.2× 43 0.7× 40 1.0k
F. Provost France 16 462 1.5× 286 1.0× 81 0.5× 92 0.7× 23 0.4× 26 992
Esmeralda Juárez Mexico 14 270 0.9× 305 1.0× 74 0.5× 179 1.4× 27 0.5× 42 852
Riana Cockeran South Africa 17 494 1.7× 145 0.5× 37 0.2× 188 1.4× 45 0.8× 40 922
Duygu Fındık Türkiye 19 211 0.7× 197 0.7× 68 0.4× 246 1.9× 55 0.9× 61 771
Claudia Carranza Mexico 15 342 1.1× 435 1.5× 124 0.8× 177 1.4× 23 0.4× 30 904
Jennifer R. Honda United States 21 938 3.1× 634 2.1× 100 0.6× 209 1.6× 39 0.7× 65 1.3k
Anand Srinivasan United States 12 216 0.7× 356 1.2× 165 1.1× 315 2.4× 33 0.6× 23 890

Countries citing papers authored by Mina Ebrahimi‐Rad

Since Specialization
Citations

This map shows the geographic impact of Mina Ebrahimi‐Rad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Ebrahimi‐Rad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Ebrahimi‐Rad more than expected).

Fields of papers citing papers by Mina Ebrahimi‐Rad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Ebrahimi‐Rad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Ebrahimi‐Rad. The network helps show where Mina Ebrahimi‐Rad may publish in the future.

Co-authorship network of co-authors of Mina Ebrahimi‐Rad

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Ebrahimi‐Rad. A scholar is included among the top collaborators of Mina Ebrahimi‐Rad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Ebrahimi‐Rad. Mina Ebrahimi‐Rad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larijani, Bagher, Maryam Mohammadi‐Khanaposhtani, Aydın Aktaş, et al.. (2025). 4-Phenylthiazol-1,2,3-triazole derivatives as new potential α-glucosidase and α-amylase inhibitors. Journal of Molecular Structure. 1334. 141919–141919. 3 indexed citations
2.
Ebrahimi‐Rad, Mina, et al.. (2023). High prevalence of antibiotic resistance and biofilm formation in Salmonella Gallinarum. Iranian Journal of Microbiology. 15(5). 631–641. 3 indexed citations
4.
Ebrahimi‐Rad, Mina, Shohreh Khatami, Mahdi Mahmoudi, et al.. (2020). Evaluation of autoantibodies against vimentin and α-enolase in rheumatoid arthritis patients. Reumatologia/Rheumatology. 58(6). 350–356. 8 indexed citations
5.
Sadeghi, Golnar, Mina Ebrahimi‐Rad, Ali Eslamifar, et al.. (2020). In vivo and in vitro Pathogenesis and Virulence Factors of Candida albicans Strains Isolated from Cutaneous Candidiasis. Iranian Biomedical Journal. 24(5). 319–327. 8 indexed citations
7.
Ebrahimi‐Rad, Mina, et al.. (2019). Salmonella Typhimurium in Iran: Contribution of molecular and IS200 PCR methods in variants detection. PLoS ONE. 14(3). e0213726–e0213726. 10 indexed citations
9.
Sadeghi, Golnar, Mina Ebrahimi‐Rad, Seyed Fazlollah Mousavi, Masoomeh Shams‐Ghahfarokhi, & Mehdi Razzaghi‐Abyaneh. (2018). Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile. Journal de Mycologie Médicale. 28(1). 51–58. 69 indexed citations
10.
Johari, Behrooz, Mina Ebrahimi‐Rad, Majid Lotfinia, et al.. (2018). Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells. Anti-Cancer Agents in Medicinal Chemistry. 17(13). 1786–1795. 21 indexed citations
11.
Shokri, Mehdi, et al.. (2017). Expression of Leishmania major LmSTI1 in Yeast Pichia Pastoris. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Rahimi, Siavash, et al.. (2017). Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production. 4(3). 72–80. 2 indexed citations
13.
Ebrahimi‐Rad, Mina, et al.. (2017). Prevalence of congenital cytomegalovirus infection in symptomatic newborns under 3 weeks in Tehran, Iran. BMC Infectious Diseases. 17(1). 688–688. 4 indexed citations
14.
Ebrahimi‐Rad, Mina, et al.. (2017). Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia. Journal of Medical Biochemistry. 37(2). 128–133. 19 indexed citations
15.
Larijani, Bagher, et al.. (2016). Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus. Enzyme Research. 2016. 1–6. 14 indexed citations
17.
Ahmadzadeh, Arman, et al.. (2016). Accuracy of a fracture risk assessment tool in Iranian osteopenic and osteoporotic women. 1(1). 15–19. 1 indexed citations
18.
Niemann, Stefan, Muhammad Gulfraz, Mazhar Qayyum, et al.. (2013). Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in Punjab, Pakistan.. Pakistan Journal of Zoology. 45(1). 93–100. 17 indexed citations
19.
Saghiri, Reza, et al.. (2011). Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern. Rheumatology International. 32(6). 1633–1638. 34 indexed citations
20.
Ebrahimi‐Rad, Mina, et al.. (2004). A NOVEL VECTOR FOR EXPRESSION/SECRETION OF PROPERLY FOLDED EUKARYOTIC PROTEINS: A COMPARATIVE STUDY ON CYTOPLASMIC AND PERIPLASMIC EXPRESSION OF HUMAN EPIDERMAL GROWTH FACTOR IN E. COLI. 8(2). 51–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026